Rapid Micro Biosystems Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $6.34M Beat $6.15M Estimate
Rapid Micro Biosystems Q4 EPS $(0.26) Beats $(0.30) Estimate, Sales $6.34M Beat $6.15M Estimate
Rapid Micro Biosystems第四季度每股收益美元（0.26美元）超過預期（0.30美元），銷售額634萬美元超過預期的615萬美元
Rapid Micro Biosystems (NASDAQ:RPID) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 33.33 percent increase over losses of $(0.39) per share from the same period last year. The company reported quarterly sales of $6.34 million which beat the analyst consensus estimate of $6.15 million by 3.04 percent. This is a 44.88 percent increase over sales of $4.37 million the same period last year.
Rapid Micro Biosystems（納斯達克股票代碼：RPID）公佈的季度虧損爲每股0.26美元，比分析師共識估計的0.30美元（0.30美元）高出13.33％。這比去年同期每股虧損0.39美元（0.39美元）增長了33.33％。該公司公佈的季度銷售額爲634萬美元，比分析師普遍預期的615萬美元高出3.04％。這比去年同期的437萬美元銷售額增長了44.88％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。